South Africa’s WTO ambassador on the logic behind a COVID-19 IP waiver
“South Africa, Mlumbi-Peter said, was fully aware that IP was not the only barrier to ramping up vaccine production. Voluntary licences, technology transfer and the sharing of clinical data as well as trade secrets could all play a part in what she called the toolkit of combating the pandemic.”
